• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTFX-29
Device Problems Perivalvular Leak (1457); Device Dislodged or Dislocated (2923); Central Regurgitation (4068)
Patient Problems Valvular Insufficiency/ Regurgitation (4449); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 03/18/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: product id: d-evolutfx-2329, product type: delivery catheter system (dcs).  medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that during implant of this transcatheter bioprosthetic valve into a patient with a heavily calcified native bicuspid valve with horizontal angulation (approx 65 degrees) and a short ascending aorta, a pre implant balloon aortic valvuloplasty (bav) was performed using a 24 mm non-medtronic true balloon.The physician had difficulties placing the pigtail catheter due to a "heavy jet".The physician also reported difficulties positioning the delivery catheter system (dcs).The physician attempted to deploy the valve after several attempts to place the dcs inside the annulus.The valve was recaptured once. after deploying the valve again to the point of no recapture, the valve remained stable and the physician decided to fully release the valve.After removing the nosecone of the dcs into the descending aorta, the valve dislocated from the non coronary cusp (ncc).The patient remained stable during the procedure.Moderate aortic regurgitation and a diastole pressure of around 45mmhg were reported.The dislodged valve was then snared using two snare catheters into the ascending aorta.A second evolut valve, dcs and compression loading system (cls) were used.The replacement valve was implanted successfully inside the annulus.The procedure ended with good hemodynamics according to the physician.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Updated b5.Updated h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received which reported that the moderate ar was classified as paravalvular leak (pvl).The deployment starting point was the bottom of the pigtail catheter.The direction of the dislodgement was aortic.The implant depth after the dislodgement on the non-coronary cusp (ncc) could not be judged accurately according to the physician, but it was several mm above the annulus.The implant depth on the left coronary cusp (lcc) was around 1mm.There are no information available regarding the wire used in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18942702
MDR Text Key338148113
Report Number2025587-2024-01786
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEVOLUTFX-29
Device Catalogue NumberEVOLUTFX-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received03/20/2024
Supplement Dates Manufacturer Received03/28/2024
Supplement Dates FDA Received04/02/2024
Date Device Manufactured12/02/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H11...
Patient Outcome(s) Required Intervention;
-
-